Advanced Computing in the Age of AI | Tuesday, October 4, 2022

INDRC Announces 2022 Conference on AI Solutions for Neurodegenerative Disorders 

PRAGUE, Aug. 17, 2022 — INDRC, the International Neurodegenerative Disorders Research Center, a private, non-profit, global research institute established to apply artificial intelligence (AI) and machine learning (ML) solutions to identify and validate therapeutic interventions for Alzheimer’s disease and other neurodegenerative disorders, today announced the launch of the INDRC Conference 2022: “Artificial Intelligence Solutions for Understanding and Treatment of Neurodegenerative Disorders.”

The conference will be held on September 7 and 8, 2022, in Prague, Czech Republic, under the auspices of the Czech Ministry for EU Affairs. It is organized as the official part of the Czech Presidency of the Council of the European Union in the Fall of this year, on the occasion of the meeting of the Council of EU Ministers for Health.

“INDRC is a pioneering institute, and the first of its kind to combine biological sciences and medicine with big data and artificial intelligence approaches to study the function and information processing of human brain, with the goal of improving treatment and prevention of neurodegenerative disorders,” said Martin Tolar, MD, PhD, Founder and Chairman of INDRC Executive Board. “The initial focus of the institute is to address the major public health demand for improved understanding of the biology driving neurodegeneration and new interventions to treat these devastating diseases.”

The INDRC was established to address the challenges facing the identification and validation of new interventions for neurodegenerative disorders. INDRC uses a transparent governance model that includes committed international partners from the European Union, North America and around the world, including universities, research institutes, clinical centers, and for-profit/non-profit companies. The Institute applies AI and ML to develop novel integrated analytical methods using an interdisciplinary approach.

“A key obstacle to the development of new therapies is the lack of understanding of the complex non-linear networked relationships between the behavioral and clinical features of a given brain disorder with the underlying neurobiological mechanism,” said Ara Khachaturian, PhD, Chair of INDRC Scientific Advisory Board and Executive Vice President of Campaign to Prevent Alzheimer’s Disease. “At present, the neuroscience research communities do not have easy access to data and interpretation tools, which typically reside within advanced and high-performance computing laboratories and often require highly qualified technicians, programmers, engineers, and computer scientists. These disciplines are rarely associated with biomedical research focused on brain disorders, and researchers do not currently possess adequate conceptual models of brain diseases, the requisite research mapping tools, or the knowledge visualization systems to efficiently investigate new and promising interventions that connect the complex origins of brain disorders with the clinical symptoms,” Dr. Khachaturian stressed. “Given the recent challenges of clinical trials to demonstrate effective options to modify the clinical course of Alzheimer’s and other forms of dementia, INDRC’s primary research priority is to slow the progression and delay the onset of disabling symptoms, so that people living with dementia and other chronic brain disorders may maintain their personal independence.”

INDRC seeks the establishment of a novel modelling framework to formally examine current theories, as well as clinical and biological knowledge comprising Alzheimer’s disease and neurodegeneration. This effort will:

  • Create an inventory of knowledge about various theories.
  • Provide a knowledge management platform of these theories.
  • Establish a common ontology to identify the most crucial aspects that provide linkages, coupling and/or interfaces between and among the various sub-systems within the complete brain architecture.
  • Construct a high-performance AI/ML model platform – “Modelbase” – to integrate and explore currently available conceptual knowledge and experimental data.

Combining existing biological brain research and AI/ML computational expertise faces numerous challenges that INDRC was designed to overcome. INDRC aims to mitigate knowledge dispersity by developing new methods, models, and algorithms to enable exploration of the complex non-linear dynamics between biology, environment, disease, and public health. The combination of computational and scientific progress provides tremendous opportunities to advance understanding of neurodegeneration and potential interventions to help patients suffering from devastating neurodegenerative disorders.

The INDRC concept offers fresh perspectives through deployment of AI/ML methods and technologies in all possible layers, such as:

  • AI/ML-enhanced diagnostics, e.g., autonomous cognitive assessment, audio & video analysis.
  • Novel therapeutic solutions, e.g., ML for protein engineering and new biologically active molecules.
  • AI/ML-enhanced assistance for patients and caregiver care, e.g., assistive devices for home care and telemedicine.
  • Prevention and brain health insights for health systems, primary care physicians, and individuals, e.g., big data processing of social, professional, and lifestyle impacts to individual patients.

INDRC strives to enable stronger collaboration and communication within the scientific community to reduce unnecessary duplication of efforts. The institute aims to facilitate communication within research networks, initiatives, and teams, enabling partners to learn from each other and generate synergies.

About INDRC

The INDRC, International Neurodegenerative Disorders Research Center, is a private, non-profit, global research institute based in Prague, Czech Republic, that for the first time combines biological sciences and medicine with big data and artificial intelligence approaches to study and treat Alzheimer’s disease and other neurodegenerative disorders. The INDRC goal is to merge and advance the globally dispersed knowledge in brain systems and neurodegeneration through research training fellowship programs of excellence, delivering outstanding independent research programs, building a world-class research community, and enabling technological and therapeutic innovations with genuine impact on society and humanity. INDRC is interdisciplinary by design, addressing research bottlenecks and developing new analytical approaches to discover and model the non-linear dynamics between biology, disease, man, and environment. The Institute uses a transparent governance model that includes committed international partners from European Union, North America and around the world, including universities, research institutes, clinical centers, and for-profit/non-profit companies. INDRC projects apply artificial intelligence and machine learning to address the challenges facing the identification and validation of new therapeutic interventions in Alzheimer´s and other neurodegenerative disorders to advance therapies with the greatest impact for patients.


Source: INDRC

About the author: Tiffany Trader

With over a decade’s experience covering the HPC space, Tiffany Trader is one of the preeminent voices reporting on advanced scale computing today.

Add a Comment

EnterpriseAI